Stockreport

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints [Fortune]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The Danish producer of Ozempic, Wegovy, and Semaglutide said clinical trials had demonstrated that overweight subjects using the weight-loss drug Cagrisema had lost an [Read more]